FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

164611000001107: Retin-A 0.01% gel (Janssen-Cilag Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16665701000001117 Retin-A 0.01% gel (Janssen-Cilag Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
16665801000001114 Retin-A 0.01% gel (Janssen-Cilag Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Retin-A 0.01% gel (Janssen-Cilag Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Retin-A 0.01% gel (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Retin-A 0.01% gel (Janssen-Cilag Ltd) Is a Product containing precisely tretinoin 100 microgram/1 gram conventional release cutaneous gel true Inferred relationship Existential restriction modifier
Retin-A 0.01% gel (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Retin-A 0.01% gel (Janssen-Cilag Ltd) Has excipient Butylated hydroxytoluene false Inferred relationship Existential restriction modifier
Retin-A 0.01% gel (Janssen-Cilag Ltd) Has active ingredient Tretinoin false Inferred relationship Existential restriction modifier
Retin-A 0.01% gel (Janssen-Cilag Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Retin-A 0.01% gel (Janssen-Cilag Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Retin-A 0.01% gel (Janssen-Cilag Ltd) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Retin-A 0.01% gel (Janssen-Cilag Ltd) Is a Retin-A true Inferred relationship Existential restriction modifier
Retin-A 0.01% gel (Janssen-Cilag Ltd) Has specific active ingredient Tretinoin true Inferred relationship Existential restriction modifier
Retin-A 0.01% gel (Janssen-Cilag Ltd) Has dispensed dose form Gel true Inferred relationship Existential restriction modifier
Retin-A 0.01% gel (Janssen-Cilag Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Retin-A 0.01% gel (Janssen-Cilag Ltd) VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Retin-A 0.01% gel (Janssen-Cilag Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Retin-A 0.01% gel (Janssen-Cilag Ltd) 60 gram Is pack of False Retin-A 0.01% gel (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier
Retin-A 0.01% gel (Janssen-Cilag Ltd) 60 gram Has AMP True Retin-A 0.01% gel (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start